Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-01-23 Sale | 2019-01-25 4:38 pm | CURIS INC | CRIS | Kunkel Lori Anne Director | 14,800 | $1.0528 | $15,581 | 22,200 (Direct) | View |
| 2018-10-01 Sale | 2018-10-03 5:05 pm | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 5,000 | $170.37 | $851,829 | 22,344 (Direct) | View |
| 2018-06-14 Sale | 2018-06-18 5:00 pm | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 39,232 | $179.83 | $7,055,254 | 37,919 (Direct) | View |
| 2018-04-20 Sale | 2018-04-24 4:30 pm | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 5,000 | $132.68 | $663,378 | 6,840 (Direct) | View |
| 2017-11-02 Sale | 2017-11-06 5:03 pm | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 5,000 | $84.91 | $424,570 | 11,840 (Direct) | View |
| 2017-08-22 Sale | 2017-08-23 6:35 pm | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 10,000 | $75.17 | $751,731 | 16,840 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-17 Option Award | 2022-06-17 8:23 pm | N/A 2032-06-16 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 53,700 | $0 | 53,700 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-06 5:23 pm | N/A 2032-05-04 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-01-31 Option Award | 2022-01-31 5:33 pm | N/A 2032-01-30 | CURIS INC | CRIS | Kunkel Lori Anne Director | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 7:48 pm | N/A 2031-06-15 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 16,625 | $0 | 16,625 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-24 7:49 pm | N/A 2031-05-05 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 4:30 pm | N/A 2031-01-27 | CURIS INC | CRIS | Kunkel Lori Anne Director | 33,000 | $0 | 33,000 (Direct) | View |
| 2020-07-23 Ownership | 2020-07-23 6:53 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 0 | $0 | 58,332 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-10 5:09 pm | N/A 2030-06-08 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 28,515 | $0 | 28,515 (Direct) | View |
| 2020-06-09 Ownership | 2020-06-10 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 0 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 5:10 pm | N/A 2030-03-01 | CURIS INC | CRIS | Kunkel Lori Anne Director | 180,000 | $0 | 180,000 (Direct) | View |
| 2019-10-04 Option Award | 2019-10-04 8:31 pm | N/A 2029-10-03 | Tocagen Inc | TOCA | Kunkel Lori Anne Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-31 4:24 pm | N/A 2029-05-28 | Tocagen Inc | TOCA | Kunkel Lori Anne Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-01-11 Option Award | 2019-02-26 4:49 pm | N/A 2029-01-10 | Tocagen Inc | TOCA | Kunkel Lori Anne Acting-Chief Medical Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2019-02-15 Disposition | 2019-02-15 09:14 am | N/A 2024-06-18 | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 104,592 | $235 | 0 (Direct) | View |
| 2019-01-21 Option Award | 2019-01-23 4:48 pm | N/A 2029-01-20 | CURIS INC | CRIS | Kunkel Lori Anne Director | 180,000 | $0 | 180,000 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-03 5:05 pm | N/A N/A | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 5,000 | $3.648 | 22,344 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-03 5:05 pm | N/A 2024-06-18 | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 5,000 | $0 | 22,344 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:48 pm | N/A 2028-06-20 | Tocagen Inc | TOCA | Kunkel Lori Anne Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-18 5:00 pm | N/A N/A | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 27,343 | $3.648 | 37,919 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-18 5:00 pm | N/A N/A | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 1,953 | $24.18 | 37,919 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-18 5:00 pm | N/A N/A | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 3,096 | $20.91 | 37,919 (Direct) | View |
| 2018-06-14 Exercise | 2018-06-18 5:00 pm | N/A 2024-06-18 | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 32,392 | $0 | 37,919 (Direct) | View |
| 2018-06-13 Option Award | 2018-06-14 5:05 pm | N/A 2028-06-12 | Loxo Oncology Inc. | LOXO | Kunkel Lori Anne Director | 8,750 | $0 | 8,750 (Direct) | View |
| 2018-01-22 Option Award | 2018-01-24 4:47 pm | N/A N/A | CURIS INC | CRIS | Kunkel Lori Anne Director | 185,000 | $0 | 185,000 (Direct) | View |